MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
about
MicroRNAs in the Host Response to Viral Infections of Veterinary ImportanceEnvironmental chemical exposures and human epigeneticsDevelopmental and activity-dependent miRNA expression profiling in primary hippocampal neuron culturesAnimal models and conserved processesPharmaco-miR: linking microRNAs and drug effects.Acyclovir or Aβ42 peptides attenuate HSV-1-induced miRNA-146a levels in human primary brain cells.Gestational hypoxia and epigenetic programming of brain development disorders.miRNA and miRNA target genes in copy number variations occurring in individuals with intellectual disability.MicroRNAs in Human Diseases: From Autoimmune Diseases to Skin, Psychiatric and Neurodegenerative DiseasesAnalysis for the mechanism between the small cell lung cancer and non-small cell lung cancer combing the miRNA and mRNA expression profiles.MicroRNA-mediated dysregulation of neural developmental genes in HPRT deficiency: clues for Lesch-Nyhan disease?Up-regulation of NF-kB-sensitive miRNA-125b and miRNA-146a in metal sulfate-stressed human astroglial (HAG) primary cell cultures.Effect of (S)-3,5-DHPG on microRNA expression in mouse brain.MicroRNA in Aging: From Discovery to BiologyAssociation mapping of genetic risk factors for chronic wasting disease in wild deerEpigenetics: a novel therapeutic approach for the treatment of Alzheimer's diseaseDifferential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells.Upregulation of micro RNA-146a (miRNA-146a), a marker for inflammatory neurodegeneration, in sporadic Creutzfeldt-Jakob disease (sCJD) and Gerstmann-Straussler-Scheinker (GSS) syndrome.Environmental chemicals and microRNAs.Increased expression of miRNA-146a in Alzheimer's disease transgenic mouse models.Epigenetic treatments for cognitive impairmentsRole of microRNAs in central nervous system development and pathology.MicroRNAs in neurodegenerative diseases and their therapeutic potential.Atrial remodeling in atrial fibrillation and some related microRNAs.Noncoding RNAs in Neurodegenerative DiseasesRNA processing-associated molecular mechanisms of neurodegenerative diseases.Functional genomics approach for identification of molecular processes underlying neurodegenerative disorders in prion diseases.Phenotypic changes in calbindin D28K immunoreactivity in the hippocampus of Fmr1 knockout mice.Regulation of MicroRNAs-Mediated Autophagic Flux: A New Regulatory Avenue for Neurodegenerative Diseases With Focus on Prion Diseases.A workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson's disease.Integrative analyses of genes and microRNA expressions in human trisomy 21 placentas.MiRAR-miRNA Activity Reporter for Living Cells.
P2860
Q28078710-B17CF69E-AEA8-4DCC-B42F-7319F16D2557Q28397621-A9CF3547-3C23-4C65-95B6-9468738178F0Q28534050-21535AFB-47E3-4C5C-8C23-53312A64E6CBQ28710144-2E9A4545-0DE0-46BF-98A6-E6ED08A82C79Q33920265-6B5FC9D5-3945-4F4C-9B6A-0B83A062A6B1Q34191283-EFD1C076-88B4-4811-BE92-8902830CB077Q34674453-FDBFE75F-34A9-41E6-ADDE-B41A727089FDQ34928893-5DA5DB07-F5D0-4D36-9BB2-B940376CBE19Q35624533-C067270F-6003-4159-AF53-63992A8EDE45Q35663529-8E7B5CE0-3D00-4978-B8A5-6F285B68C94CQ35674697-598F339D-B8A6-47B7-9035-C99003091769Q35929293-3336C8C1-B020-40A3-BD70-C8DEBAB4600FQ35935936-08A8974B-0850-4136-AEEB-DE1A4144D603Q36310536-22ECB521-3025-423D-BA05-DFADA02C38C9Q36651717-82183B38-4C8A-4564-880E-855D923D192BQ36956287-22D20097-1B33-4573-AD74-296D23E63F07Q37019363-3A594D15-E1AA-4C34-804F-8A863E2CCE2AQ37036921-F951B7C0-B577-4F2D-AC35-D561B07740A3Q37084568-87C095D3-2D0D-4387-8166-B12E3E5291C4Q37739709-24462F70-9B9D-43E3-8BCA-AC986ABB0E85Q37877119-BC91D651-4636-4815-ABBA-6CC21F9BB989Q37933185-45027E36-1A00-4CE7-9E9F-29FD0CB4066DQ37946984-9B6DA4F9-9A7F-46A9-9A90-F3BD7AA4D83CQ37969565-C794F059-F9F4-46AB-A067-94F6CD6C9DB1Q38112127-EB2B05D4-5285-49D3-ACD0-A51D15B1FAD7Q38658613-54115E2D-B0BA-4C2F-AD1E-BF9E62931D02Q39474448-3BDFF6DB-BA6B-4A04-BE4A-EDA0391D2C82Q51012749-87885BFB-F68B-4653-BBFC-43758C24988CQ55004951-BA135D41-FDCA-433F-B00B-DEE13A2E9586Q55063113-0782C20D-643C-45D8-B33E-A204C4949C08Q55088661-F514904B-22F6-4252-A2F3-A75F1DECE1A2Q55603693-5533EB24-1A2D-4CF1-8EC0-E97E9CAC083B
P2860
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
@ast
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
@en
type
label
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
@ast
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
@en
prefLabel
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
@ast
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
@en
P2860
P1433
P1476
MicroRNAs as a molecular basis for mental retardation, Alzheimer's and prion diseases.
@en
P2093
Patrick Provost
P2860
P356
10.1016/J.BRAINRES.2010.03.069
P407
P577
2010-03-27T00:00:00Z